Nanoview Biosciences
Boston
About Nanoview Biosciences
nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.3M
- Funding stage: M&A
- Last round: Debt Financing (Mar 2022)
- Website: nanoviewbio.com
- Phone: +1-781-365-8439
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/nanoview-biosciences-22147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.